NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 319 filers reported holding NOVOCURE LTD in Q3 2021. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,476,675 | -46.6% | 91,435 | +37.2% | 0.82% | -39.2% |
Q2 2023 | $2,765,768 | +11.1% | 66,645 | +61.0% | 1.35% | -0.7% |
Q1 2023 | $2,489,856 | -19.3% | 41,401 | -1.6% | 1.36% | -22.3% |
Q4 2022 | $3,085,174 | -9.6% | 42,061 | -6.4% | 1.75% | -1.6% |
Q3 2022 | $3,413,000 | -28.7% | 44,918 | -34.8% | 1.78% | -28.6% |
Q2 2022 | $4,789,000 | -20.8% | 68,908 | -5.6% | 2.49% | +11.0% |
Q1 2022 | $6,049,000 | +73.7% | 73,014 | +57.4% | 2.24% | +105.8% |
Q4 2021 | $3,482,000 | -34.6% | 46,376 | +1.2% | 1.09% | -36.5% |
Q3 2021 | $5,326,000 | -22.6% | 45,848 | +47.7% | 1.72% | -20.2% |
Q2 2021 | $6,884,000 | +7.1% | 31,035 | -36.2% | 2.15% | +8.5% |
Q1 2021 | $6,430,000 | -24.1% | 48,649 | -0.7% | 1.98% | -28.8% |
Q4 2020 | $8,477,000 | +62.4% | 48,990 | +4.5% | 2.78% | +21.0% |
Q3 2020 | $5,220,000 | +90.1% | 46,896 | +1.3% | 2.30% | +68.6% |
Q2 2020 | $2,746,000 | -48.2% | 46,304 | -41.2% | 1.36% | -38.7% |
Q1 2020 | $5,305,000 | +65.4% | 78,780 | +106.9% | 2.23% | +0.7% |
Q4 2019 | $3,208,000 | +4.1% | 38,073 | -7.6% | 2.21% | -0.8% |
Q3 2019 | $3,081,000 | +4.6% | 41,198 | -11.6% | 2.23% | +9.1% |
Q2 2019 | $2,946,000 | +43.9% | 46,599 | +9.7% | 2.04% | +28.4% |
Q1 2019 | $2,047,000 | +39.9% | 42,489 | -2.7% | 1.59% | +23.7% |
Q4 2018 | $1,463,000 | – | 43,686 | – | 1.29% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Nordwand Advisors, LLC | 1,515,000 | $111,125,249 | 13.86% |
Invus Financial Advisors, LLC | 350,884 | $25,737,341 | 13.70% |
HARTLINE INVESTMENT CORP/ | 304,482 | $22,333,755 | 5.08% |
GREAT POINT PARTNERS LLC | 241,000 | $17,677,350 | 3.46% |
Tri Locum Partners LP | 72,400 | $5,311,000 | 2.15% |
Taylor Frigon Capital Management LLC | 42,061 | $3,085,174 | 1.75% |
HighVista Strategies LLC | 28,007 | $2,054,313 | 1.22% |
HAP Trading, LLC | 124,500 | $10,294 | 1.05% |
Private Harbour Investment Management & Counsel, LLC | 12,285 | $901,105 | 0.99% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 32,000 | $2,344,000 | 0.72% |